FDA Approves Wezlana (ustekinumab-ttwe) for Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, and Ulcerative Colitis
FDA approves Wezlana, a biosimilar to Stelara, for several inflammatory conditions.
The FDA approved Wezlana (ustekinumab-ttwe), a biosimilar to Stelara, for moderate to severe plaque psoriasis, active psoriatic arthritis, m…
The FDA approved Wezlana (ustekinumab-ttwe), a biosimilar to Stelara, for plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcera…
FDA Approves Wezlana (ustekinumab-ttwe) for Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, and Ulcerative Colitis
FDA approves Wezlana, a biosimilar to Stelara, for inflammatory conditions.
The FDA approved Wezlana (ustekinumab-ttwe), a biosimilar to Stelara, for multiple indications including plaque psoriasis, psoriatic arthrit…
The FDA approved Wezlana, a biosimilar to Stelara, for plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. It of…
FDA Approves Siliq (brodalumab) for Moderate to Severe Plaque Psoriasis
FDA approves new drug Siliq for adults with plaque psoriasis
The FDA approved Siliq (brodalumab) for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or photother…
The FDA approved Siliq (brodalumab) for adults with moderate to severe plaque psoriasis who have not responded well to other treatments. Thi…
Narrative review of treatment strategies for primary central nervous system lymphoma
A Smarter Way to Treat a Rare Brain Lymphoma Is Emerging
This narrative review covers treatment strategies for primary central nervous system lymphoma, including HD-MTX-based regimens, HDC-ASCT, an…
A rare lymphoma hiding in the brain now has sharper risk tools and smarter drug combos that could mean fewer relapses and less toxic treatme…
Review of case report suggests multimodal therapy potential for unresectable intraductal papillary mucinous neoplasms of the bile duct
At-a-Glance
This review of a case report describes two patients with unresectable intraductal papillary mucinous neoplasms of the bile duct treated with…
A new three-drug combination shrank a rare bile duct tumor in one patient and stopped another from growing, offering hope for a cancer with …
Narrative review offers theoretical basis for selecting biologic therapies in psoriasis patients with renal concerns
New Psoriasis Treatments May Protect Kidneys While Fighting Skin Flares
This narrative review examines the use of TNF-alpha, IL-17, and IL-12/23 inhibitors in psoriasis patients with renal concerns. The authors p…
• Some biologics shield kidneys from damage during psoriasis treatment • Helps the 8 million Americans with psoriasis and kidney worries • N…
Psoriatic arthritis linked to interstitial lung disease prevalence
Psoriatic Arthritis Patients Face Hidden Lung Risk Doctors Often Miss
A systematic review finds 3% of psoriatic arthritis patients have interstitial lung disease, with smoking increasing risk. Imaging-based dia…
Hidden lung scarring affects about 1 in 20 psoriatic arthritis patients, and smoking triples the risk, a new analysis shows.
Targeted therapies for psoriasis and psoriatic arthritis significantly alter lipid profiles across diverse patient populations
Psoriasis drugs change heart risk in surprising ways
A comprehensive meta-analysis of 24,575 patients reveals that targeted therapies for psoriasis and psoriatic arthritis consistently modify l…
Some common psoriasis drugs sharply raise cholesterol while others lower it, forcing doctors to rethink how they protect their patients’ hea…
Meta-analysis of sirolimus for cutaneous squamous cell carcinoma in kidney transplant recipients
Sirolimus lowers skin cancer risk in kidney transplant patients
This meta-analysis of four randomized trials in kidney transplant recipients with prior cutaneous squamous cell carcinoma found that switchi…
A review of studies shows switching to sirolimus can cut skin cancer rates, but it may cause more side effects.
Rapid review and meta-analysis of psychological distress in adults undergoing Mohs micrographic surgery
Mohs Surgery Linked To Psychological Distress In Adults
This rapid review and meta-analysis examined psychological adverse events in adults undergoing Mohs micrographic surgery.
A rapid review found psychological distress is common after Mohs surgery, with risks often missing from consent forms.
5-Fluorouracil and MAL-PDT vs Surgery for Bowen's Disease: 4-Year Outcomes
Surgery kept skin cancer away better than two light-based treatments in this trial
This multicenter RCT compared 5-fluorouracil, methylaminolevulinate photodynamic therapy (MAL-PDT), and surgical excision (SE) in 250 patien…
Surgery offered the highest chance of staying cancer-free for four years, while light-based treatments showed lower success rates in this st…
Ixekizumab shows efficacy in children with enthesitis-related and juvenile psoriatic arthritis
New drug ixekizumab shows promise for children with arthritis
This multicentre, open-label, phase 3 study evaluated ixekizumab in 101 children with enthesitis-related arthritis or juvenile psoriatic art…
A phase 3 study found ixekizumab helped many children with arthritis meet response criteria at week 16, with mostly mild side effects report…